Our Team

Caitlin Bishop

Program Manager

Caitlin Bishop, Program Manager, manages AAI members and partners in Nigeria, as well as projects across BVGH’s network of program partners. 

Before joining BVGH, Caitlin was a fundraising professional at community organizations in Washington and Arizona, and a research assistant and policy analyst at a healthcare company and health policy organization. Caitlin received her BA, Sociology and Communication, summa cum laude, from the University of Arizona and her MPA, Analysis and Evaluation, from the Evans Schools of Public Policy & Governance at the University of Washington. Her capstone project, which reviewed Washington State’s COVID-19 vaccination strategy and provided recommendations to increase vaccine uptake, was awarded the Evans School 2021 Policy and Governance Research Prize. Originally from Arizona, Caitlin loves exploring the Pacific Northwest and is most often seen hiking a new trail or enjoying local coffee, accompanied by her rescue pup, Margot.

Heather Davidson

Program Manager

Heather Davidson, Program Manager, manages AAI members in Cameroon and partners in Nigeria, along with projects across BVGH’s network of program partners.

Prior to joining BVGH, Heather was a grant writer with medical non-profits, focusing on helping marginalized populations gain access to low- or no-cost health care. Heather has many years of administrative, project-driven experience, and is a member of the Medical Writers Association. Heather has also worked as an artist and small business owner for over 10 years. Now she creates artwork for fun instead of profit. Heather received her BA, English and Art, from St. Olaf College and completed additional studies in Anatomy, Physiology, and Technical Writing. In her spare time, she loves growing food (including building a small aquaponics system), and likes settling down with her husband and their goofy cat to enjoy a movie or a good book.

Jennifer Dent

President and Chief Executive Officer

Jennifer Dent, President & CEO is responsible for setting the organization’s strategy, determining its programs, and working with the BVGH team to establish partnerships and deliver on program objectives.

She joined BVGH in 2011 and took over leadership of the organization in 2012. She has facilitated partnerships across the private, government, and public sectors involving more than 50 countries. Jennifer leverages her international industry experience to tackle tough global health challenges with market-driven approaches focusing on sustainability, scalability, and most importantly, priorities and needs as determined by each African or low- and middle-income country partner. Prior to joining BVGH, Jennifer worked for Hoffmann-La Roche as an Alliance Director in South San Francisco at the Genentech site. She has 20+ years of broad-based pharmaceutical and biotechnology experience, including negotiation and structuring of deals, and management of global discovery and commercial alliances. Jennifer began her career as a sales representative in Canada working in a variety of positions for Parke Davis/Pfizer and Genentech. Following the acquisition of Genentech Canada by Roche, Jennifer held a number of senior management positions in marketing, life cycle management, global product strategy, business development, and alliance management at Roche and Genentech in Canada, Switzerland, New Jersey, and South San Francisco. Jennifer co-founded Sound Biotechnology, and prior to that, served as Vice President, Business Development, Marketing, and Sales at CombiMatrix Corporation in Washington State.

Jennifer received her MBA from the Richard Ivey School of Business, Western University and her BSc from Western University in Canada. In her spare time, Jennifer can be found in her garden or spending time with family and friends.

Julia Franz

Associate Director

Julia Franz, Associate Director, manages African Access Initiative (AAI) members and partners in Nigeria, as well as projects across BVGH’s network of program partners.

Prior to joining BVGH, Julia was a journalist and radio producer in her home state of Minnesota, covering the COVID-19 pandemic and breaking stories for a daily news show. She has a background in nonprofit communications, and once managed projects and teams at a large industrial supplier. Julia received her BA in Comparative Literature and East Asian Languages and Literatures from Smith College, in Massachusetts. She loves reading, biking, canoeing, and spending time outside with her husband and daughter.

Katy Graef

Vice President, Programs

Katy Graef, Vice President, Programs, develops new program strategy and leads the African Access Initiative (AAI) and African Consortium for Cancer Clinical Trials (AC3T) programs.

Prior to joining BVGH, Katy completed post-doctoral training at the Rocky Mountain Laboratories in Montana where she studied tick-borne flaviviruses. She taught an undergraduate microbiology course and mentored numerous laboratory students during her undergraduate and graduate studies. Katy obtained her BS, Microbiology, honors, magna cum laude, from the University of Washington. She completed her PhD, Virology, at the University of Oxford through the NIH Oxford Cambridge Scholars Program. She serves as the Assistant Secretary to the Secretary of the BVGH Board of Directors. Katy grew up in Washington. She loves to read, which works well for her snuggly Siamese cats, Robin and Lily.

Micaella Jorge

Program Manager

Micaella Jorge, Program Manager, manages BVGH’s African Access Initiative (AAI) partners in Nigeria and facilitates infectious disease programs.

Prior to joining BVGH, Micaella conducted global health research at Vanderbilt University, where she analyzed, developed, and optimized point-of-care diagnostic tools for the detection of malaria, tuberculosis, and bacterial infections. She also worked as a freelance medical writer, covering a variety of health and scientific topics written to educate a general audience. A chemist by training, Micaella obtained her bachelor’s degree, Chemistry, from the University of San Diego. There, her interest in global health was piqued after traveling to Uganda during her senior year to learn about water quality research. Before earning her PhD, Chemistry, from Vanderbilt University, Micaella was awarded a Global Health Equity Scholar Postdoctoral Fellowship through the U.S. National Institutes of Health. Micaella is originally from Nevada, but now calls Tennessee home, where she enjoys playing card games, cuddling with her cat, Ruby, and exploring new places, both local to Nashville and abroad.

Valerie Krepel

Communications and Operations Manager

Valerie Krepel, Communications and Operations Manager, manages BVGH’s office, tracks new outreach initiatives, oversees company communications, and assists with special projects across BVGH’s network of program partners.

Before joining BVGH, Valerie was the Chief of Staff at Pius Kitchen and Bath, where she led rebranding and assisted in restructuring departments. Valerie received her BA in Multimedia from California Lutheran University, summa cum laude. Her honor’s thesis revolved around ethical and sustainable practices in agriculture, which led to a broader interest in global initiatives. Valerie is originally from Alaska and enjoys hiking, fiber crafts, and spending time with her cats, Pugsley and Pepita.

Chaja Levy

Program Manager

Chaja Levy, Program Manager, manages African Access Initiative (AAI) members and partners in Nigeria, as well as African Consortium for Cancer Clinical Trials (AC3T) and Global Innovation Alliance (GIA) members and partnerships.

Prior to joining BVGH, Chaja was a graduate research assistant and study coordinator at the University of Washington and has a background in science education and non-profit program coordination. Chaja received her BS in Environmental Science and Resource Management and her MS in Environmental Science from the University of Washington. Her thesis examined the effects of forest terpenes exposure on stress-related physiological and psychological outcomes in humans.

Chaja is originally from Nevada, but has spent most of her life in Seattle, where she enjoys reading, spending time in nature, and finding the best places to eat in town.

Sally Loos

Senior Program Manager

Sally Loos, Senior Program Manager, manages African Access Initiative (AAI) members and partners in Senegal, as well as projects across BVGH’s network of program partners.

Before joining BVGH, Sally spent a decade working in the medical humanitarian aid sector with international non-governmental organizations and Doctors Without Borders. Originally from the Midwest, she earned her bachelor’s degree in Psychology & Integrative Physiology from the University of Iowa and continued on to earn her Doctor of Chiropractic degree from Palmer College of Chiropractic, specializing in sports medicine and non-communicable disease prevention. During graduate school, Sally completed a clinic abroad rotation in Fiji, which solidified her interest in working in underserved and low-resource settings. Her shift to working in global health began in 2012 by serving in the US Peace Corps as a Health Extension Agent in Cambodia. An avid world traveler, she has traveled to and worked across more than 50 countries. Thanks to her work in Democratic Republic of Congo and Central African Republic, she is proficient in French. Sally loves cooking, traveling, running, and adventuring with her partner and their two dogs.

Cathyryne Manner

Vice President

Cathyryne “Cathy” Manner, Vice President, leads BVGH’s infectious disease programs and strategy, and plays a key role in communications. She brings broad expertise in life sciences and grant making to BVGH, as well as over 15 years of experience in catalyzing and managing partnerships to promote research, advance product development, and improve health.

Before joining BVGH, Cathy was a Senior Program Officer at the Washington State Life Sciences Discovery Fund, where she co-led grant program development, technology evaluation, award management, and communications. Previously, she was a Program Coordinator at SAIC (now Leidos), where she provided programmatic, scientific, and grant management support to the Congressionally Directed Medical Research Programs. Cathy received her BS, Biochemistry, with highest honors, from the University of California Davis, and her PhD, Biomedical Sciences (cancer and neuro-inflammation research), from the University of California San Diego. Born and raised in San Francisco, California, Cathy enjoys reading and doing word and logic puzzles.

Teddy Olberding

Program Manager

Teddy Olberding, Program Manager, manages infectious disease collaborations and special projects across BVGH’s network of program partners. 

Teddy received his BS, Public Health and Communication, magna cum laude, from Tulane University. During his junior year, he researched Aboriginal and Torres Strait Island culture and health behaviors in Australia. In his senior year, he worked with SightSavers to evaluate the effectiveness of various water, sanitation, and hygiene campaigns designed to decrease the prevalence of various neglected tropic diseases among underserved global populations. Teddy is a native of Cincinnati, Ohio. In his spare time, he enjoys filmmaking and analysis, and playing soccer. He is also active in sports media, including spending some of his weekends assisting in the Cincinnati Bengals’ press box.

Kyle Peet

Senior Program Manager

Kyle Peet, Senior Program Manager, manages African Consortium for Cancer Clinical Trials (AC3T) and Global Innovation Alliance (GIA) members and partnerships, as well as African Access Initiative (AAI) projects.

Before joining BVGH, Kyle was a professor and researcher in higher education. He taught a diverse range of life and environmental science topics including microbiology, cell and molecular biology, global health, sustainability, and climate change. Kyle completed a BS in Biology and Biotechnology from Worcester Polytechnic Institute, and a PhD and post-doctoral research in Environmental Biology from Massachusetts Institute of Technology. 

Kyle grew up in Massachusetts, but now calls Washington home. He enjoys spending time with his wife and son, outdoor adventures (climbing, hiking, and biking), travel, and cooking. He has two cats, Margot and Richie.

Eleanor Plaunt

Program Manager

Eleanor Plaunt, Program Manager, manages AAI members and partners in Kenya, facilitates infectious disease collaborations, and manages projects across BVGH’s network of program partners.

Before joining BVGH, Eleanor was a research assistant for the Childhood Cancer Survivorship Program and a Policy Consultant with the Children’s Cancer Research Fund. Eleanor received her BS, Sociology of Organizations, Business, and Nonprofits, and her MPH, Community Health Promotion, from the University of Minnesota. Her master’s project focused on the need for multi-level interventions to address childhood cancer, specifically regarding childhood cancer policy and advocacy efforts to increase funding for research and improve survivorship care practices. Eleanor hails from Minnesota and enjoys spending her time on the slopes and on the trails.

Ashly Senske

Program Manager

Ashly Senske, Program Manager, manages AAI members and partners in Nigeria, facilitates infectious disease collaborations, and manages projects across BVGH’s network of program partners.

Before joining BVGH, Ashly participated in the development of new seed technologies at Germain’s Seed Technology, and assisted research at Altius Institute for Biomedical Sciences. Ashly received her BS, Biology, from the University of Washington, with a focus in conservation, ecology, and evolution. She completed her MS, Horticulture, from Iowa State University where her research – focused on the sustainability and potential implementation of perennial agriculture on Iowa farms – led her to an interest in global food security and global health. Ashly volunteers for Minds Matter Seattle as Co-Director of Senior Mentoring and as a Writing and Critical Thinking instructor. Ashly was born and raised in Iowa. She spends her free time reading, cooking, and hanging out with her cats, (aptly named) Dumpling and Ravioli.

Ellie Weisblat

Program Manager

Ellie Weisblat, Program Manager, manages BVGH’s African Access Initiative (AAI) members and partners in Cameroon and Tanzania, along with projects across BVGH’s network of program partners.

Before joining BVGH, she worked as a member of the Foodborne Illness Unit at the Minnesota Department of Health. Ellie received her BS, Biology, and BA, Spanish, from Gonzaga University, and her MPH, Epidemiology with a graduate minor in Global Health, from the University of Minnesota. Her interest in global health began after spending a month in Chimfunshi, Zambia, doing field biology work and observing the local health clinic. Ellie is originally from Spokane, Washington and now lives in Saint Paul, Minnesota. In her spare time, she enjoys running with her running club, spending time outdoors, and trying new recipes in the kitchen.

Our Board of Directors

James Geraghty

Chairman, BVGH Board of Directors; Chairman, Idera Pharmaceuticals; Chairman, Pieris Pharmaceuticals; Chairman, Orchard Therapeutics

Jim Geraghty is an industry leader with over 30 years of strategic experience, including more than 25 years as a senior executive at biotechnology companies developing and commercializing innovative therapies. 

Mr. Geraghty is chairman of the boards of Idera and Pieris Pharmaceuticals and of Orchard Therapeutics, and a member of the board of Voyager and Fulcrum Therapeutics. He was from 2013-16 an entrepreneur in residence at Third Rock Ventures, and before that served as senior vice president, North America strategy and business development at Sanofi. He spent over 20 years at Genzyme, one of the world’s leading biotech companies, as senior vice president of international development, president of Genzyme Europe, and founding president and CEO of Genzyme Transgenics. He started his career in healthcare strategy consulting at Bain. A graduate of the Yale Law School, Mr. Geraghty also holds a Master’s degree from the University of Pennsylvania and a Bachelor’s degree from Georgetown.

Ruth Atherton

Assistant General Counsel, Genentech

Ruth Atherton is the Secretary of the BVGH Board of Directors. She is an experienced pharmaceutical, biotechnology, and global health professional with expertise in risk management, global product development, complex transactions, and intellectual property. A strategic advisor, recognized for technical acumen, innovation, and culture development, Ruth is a data driven, impact-focused problem solver. Ruth has extensive international experience and unique insights on corporate social responsibility. In 2021, Ruth joined The Commons Project Foundation as their first Chief Legal Officer.

From 2012 to 2021, Ruth was the Deputy General Counsel and Director at the Bill & Melinda Gates Foundation. Her role included advising the Bill & Melinda Gates Medical Research Institute, developing pharma and biotech investments, enabling global R&D and commercialization, protecting reputation, and streamlining business processes. At the foundation, she was a member of the Global Health Executive team and the executive sponsor of the foundation’s Global Access Team which leads intellectual property strategy and creates affordable access to the products and developments to benefit the world’s populations who are most in need.

Prior to joining the foundation, Ruth was Sr. Corporate Counsel at Sanofi supporting global Industrial Affairs and Sr. Counsel at Genzyme Corporation responsible for Global Manufacturing and Operations. Ruth was litigation attorney at Fitzpatrick, Cella, Harper & Scinto in NYC, where she supported biotech and pharmaceutical litigation. Ruth served as a founding Advisory Board member of the UMass Venture Development Center, an award-winning incubator for emerging hi-tech and life science companies. She is the Executive Director and board member of Raising The Blues, Ltd., a nonprofit bringing interactive musical opportunities and instruments to children with unique life challenges

Ruth holds a Ph.D. in Cell and Molecular Biology from Cornell University and a J.D. from Fordham School of Law.

Jennifer Dent

President and CEO, BIO Ventures for Global Health

Jennifer Dent, President & CEO is responsible for setting the organization’s strategy, determining its programs, and working with the BVGH team to establish partnerships and deliver on program objectives.

She joined BVGH in 2011 and took over leadership of the organization in 2012. She has facilitated partnerships across the private, government, and public sectors involving more than 50 countries. Jennifer leverages her international industry experience to tackle tough global health challenges with market-driven approaches focusing on sustainability, scalability, and most importantly, priorities and needs as determined by each African or low- and middle-income country partner. Prior to joining BVGH, Jennifer worked for Hoffmann-La Roche as an Alliance Director in South San Francisco at the Genentech site. She has 20+ years of broad-based pharmaceutical and biotechnology experience, including negotiation and structuring of deals, and management of global discovery and commercial alliances. Jennifer began her career as a sales representative in Canada working in a variety of positions for Parke Davis/Pfizer and Genentech. Following the acquisition of Genentech Canada by Roche, Jennifer held a number of senior management positions in marketing, life cycle management, global product strategy, business development, and alliance management at Roche and Genentech in Canada, Switzerland, New Jersey, and South San Francisco. Jennifer co-founded Sound Biotechnology, and prior to that, served as Vice President, Business Development, Marketing, and Sales at CombiMatrix Corporation in Washington State.

Jennifer received her MBA from the Richard Ivey School of Business, Western University and her BSc from Western University in Canada. In her spare time, Jennifer can be found in her garden or spending time with family and friends.

Julie Gralow

Chief Medical Officer and Executive Vice President, American Society of Clinical Oncology (ASCO)

Dr. Gralow is the Chief Medical Officer (CMO) and Executive Vice President of ASCO, and brings to her role deep expertise in patient care, research, education, and global health.

Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. Dr. Gralow is strongly committed to advancing equity in cancer care. As founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), she supports patient advocates in low- and middle-resource countries. In addition, she served as an adjunct professor in the University of Washington’s Department of Global Health, as a member of the University of Washington’s Breast Cancer Equity Initiative, as Medical Director for Women’s Cancer-related Population Health at the University of Washington, and as an advisory council member for the Uganda Cancer Institute’s adult Hematology/Oncology Fellowship Training Program. Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.

She is a recognized leader in breast cancer clinical research, and has conducted clinical trials in breast cancer prevention, treatment, and survivorship. Dr. Gralow served in leadership roles for the SWOG Cancer Research Network funded by the National Cancer Institute (NCI), including as Vice Chair of the Breast Cancer Committee and Executive Officer of Breast and Lung Cancer.

Before joining ASCO full-time, Dr. Gralow served the Society in a variety of volunteer and leadership roles, including chairing the ASCO Academic Global Oncology Task Force, co-chairing the ASCO Resource Stratified Guideline Advisory Group, and serving on the editorial board of the European Society of Medical Oncology (ESMO)/ASCO Global Curriculum in Medical Oncology.

She also has been involved with numerous other nonprofit organizations, including Team Survivor Northwest, an exercise and fitness program for woman cancer survivors which she co-founded in 1995 and serves as Team Physician; a medical advisory committee member for Cierra Sisters African American Support Group; an advisory board member of Global Focus on Cancer; and a Board member of Peace Island Medical Center, a rural access hospital in Washington State.

Dr. Gralow received her bachelor’s degree from Stanford University and her medical degree from the University of Southern California School of Medicine. She trained in internal medicine at Brigham and Women’s Hospital at Harvard Medical School and completed a medical oncology fellowship at University of Washington/Fred Hutchinson Cancer Research Center in Seattle.

Serigne Magueye Gueye

Director General, Campus Franco-Sénégalais; Professor of Urology, University Cheikh Anta DIOP Dakar

Dr. Serigne-Magueye Gueye is Professor of Urology at University Cheikh Anta DIOP, Dakar, Senegal and Chair of Urology, Hospital General de Grand Yoff. He currently serves as Director General of the “Campus Franco-Senegalais.” He is a former Fulbright Senior Scholar, University of Pennsylvania School of Medicine, Philadelphia.

Dr. Gueye is Director of IFRU-SF, a non-profit organization dedicated to building capacity and developing research in Urology and Reproductive health throughout Africa. Prof. Gueye is an active clinician with a focus on urologic oncology, male sexual and reproductive health, and urogenital reconstructive surgery. In addition to the BIO Ventures for Global Health (BVGH) Board of Directors, he is a former member of the Board of Directors of the SIU at the Union for International Cancer Control (UICC), and President of the West African College of Surgeons (WACS). He is past President of the Pan African Urological Surgeons Association (PAUSA). Dr. Gueye is involved in the UNFPA-led End Fistula campaign. He runs training workshops in many sub-Saharan African countries. He has served as an expert on the steering committee of the FIGO-led, competency-based fistula training manual. He has served as an expert for accreditation of training centers for obstetric fistula for FIGO. Dr. Gueye is a member of many professional associations and has published more than 120 papers in peer-reviewed journals. Dr. Gueye is one of the experts and senior surgeon for the development of the Fistula Video trainer in collaboration with Medical Simulation International, Red Llama, and FIGO.

He has served as a field surgeon for the United Nations Assistance Mission in Rwanda (UNAMIR II) during the Rwandan Genocide. For his work, Dr. Gueye has received national and international awards, including the United Nations Medal for Peace in Rwanda (1994), as well as the medals of Officer of the Order of Merit of France, Officer of the Order of Lion Order, Senegal, and Officer of the Order of Merit of Senegal

John Nevergole

Co-Founder and CEO, ABD Group

John Nevergole is co-founder and CEO of the ABD Group. John has lead investments and projects in countries in every region of Africa and has been involved in over $2 billion USDs of investment across the continent. Outside of Africa John has advised on transactions in Colombia, Brazil and the United Sates.

In these various capacities he has partnered with and advised leaders of Fortune 500 firms, government leaders, and investors in sectors including aviation, agriculture, energy/infrastructure, healthcare, mining, and telecommunications. John is a Senior Advisor to Rosemont Seneca Advisors.

Previously John was the founder of Team One Parking, a parking company with activities in Philadelphia and was the accountant for the Southeastern United States in ARAMARK’s Healthcare Division. John has a BS from the University of Maryland and a MBA from Babson College. Additionally, John is a founding board member of SOS du Coeur.

J. Leighton Read

Venture Partner, Palo Alto

Leighton Read is the Treasurer of the BVGH Board of Directors. He is an American serial entrepreneur and venture investor with a long track record of building companies that have commercialized important medicines and life-science technologies. 

From 2000 – 2008 he was a managing director of Alloy Ventures, an early-stage firm investing in life science and technology companies. As a Venture Partner today, Leighton continues to manage his portfolio of companies at Alloy. Leighton joined Brandon Capital, a Venture firm in Australia, as a Venture Partner in 2014 where he manages a growing portfolio of companies and advises the firm on investments.

Previously, he founded Affymax NV (with Alejandro Zaffaroni) where he served as Managing Director and President of the Pharma Division, sold to Glaxo SmithKline and spun out Affymetrix and Maxygen.  He was the founding investor, Chairman and CEO of Aviron which developed FluMist™, the intranasal influenza vaccine acquired by MedImmune.  Leighton has been a director of companies ranging from biotechnology, medical devices, materials science, energy and software.  His current portfolio companies are Alexza, AnaptysBio, Cambrios, Genomatica, Siluria and Synergy Eyes.

Leighton received a B.S. from Rice University in Houston in Psychology and Biology, an MD from the University of Texas Health Science Center at San Antonio, and completed internal medicine training at Duke and the Peter Bent Brigham Hospital, where he held appointments at the Harvard Medical School and School of Public Health.  His research dealt with applications of decision theory in medicine and policy regarding medical innovation.  He produced a successful interactive game in 1984 to promote healthy lifestyles and carried this interest as Co-founder of Seriosity and co-authored (with Byron Reeves) Total Engagement: Using Games and Virtual Worlds to Change the Way People Work and Businesses Compete.

Leighton serves as a director or advisor for a number of private companies and non-profits, including The BeneTech Initiative, BIO Ventures for Global Health and The UC Berkeley School of Public Health Council.  His awards include several as co-inventor of technology underlying the Affymetrix GeneChip™ and Ernst & Young’s Northern California Life Science Entrepreneur of the Year.

Belinda Termeer

President and Co-Founder, The Termeer Foundation

Belinda Termeer is the President, Co-Founder, and Member of the Board of Directors of The Termeer Foundation. She is also the head of the Termeer family office. Belinda brings unparalleled passion to The Termeer Foundation, as well as significant experience serving on boards of directors for both nonprofit and for-profit organizations, both within and beyond the life sciences industry.

In 1998, together with her late husband, Henri Termeer (an early champion of BVGH), she started the Termeer family office and has since managed its assets. In 2011, she and Henri established the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital with the goal of developing a best-in-class center for personalized medicine, building on Henri’s work as Genzyme’s CEO focused on rare diseases. Belinda has served on the BVGH Board of Directors since 2022.

Belinda also serves as a member of the Board of Directors of PIC Therapeutics, the Board of Fellows and the Discovery Committee at Harvard Medical School, the President’s Council at Massachusetts General Hospital, the Board of Directors of Celebrity Series of Boston, the leadership council of the Silent Spring Institute, the Board of Directors of GBH, the Women in Science and Engineering Committee at the Museum of Science, and as Trustee Emerita of the Boston Ballet.